HBIO President, David Green, to Present At US Bancorp Piper Jaffray Healthcare Conference

Business Wire, Jan 24, 2003

Business Editors & Health/Medical Writers

BIOWIRE2K

HOLLISTON, Mass.--(BUSINESS WIRE)--Jan. 24, 2003

Harvard Bioscience, Inc., (Nasdaq: HBIO) today announced that its President, David Green, will present at the US Bancorp Piper Jaffray Healthcare conference in New York on Thursday January 30 at 11 am. The presentation will be webcast and will be accessible through the HBIO website at www.harvardbioscience.com.

About Harvard Bioscience, Inc.

Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily scientific instruments, used to accelerate drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. HBIO sells its products to thousands of researchers in 100 countries through its direct sales force, its 1,000 page catalog (and various other specialty catalogs), and through its distributors, including Amersham Biosciences and PerkinElmer. HBIO has sales and manufacturing operations in the United States, the United Kingdom, Germany, Austria and Belgium with sales facilities in Japan, France and Canada. For more information please visit www.harvardbioscience.com